WEDNESDAY, Dec. 21, 2022 (HealthDay News) — Elon Musk swears by the weight-loss drug Wegovy, and Kim Kardashian is rumored to have used it to shed 16 pounds in three weeks to squeeze into a vintage gown once worn by Marylin Monroe. But the intense public demand for Wegovy hasContinue Reading
MONDAY, Dec. 19, 2022 (HealthDay News) — It’s easy to blame the childhood obesity epidemic for growing cases of type 2 diabetes, but a new study finds nearly one-quarter of all diagnoses are not related to obesity. “The finding was somewhat surprising,” said Dr. Constantine Samaan, an associate professor inContinue Reading
TUESDAY, Dec. 13, 2022 (HealthDay News) — Insulin pumps can help folks with type 1 diabetes get better control of their disease and minimize how often they inject insulin, and use of the devices has taken off in the past 20 years. That’s the good news from a new study.Continue Reading
FRIDAY, Dec. 9, 2022 (HealthDay News) — Owners whose cats have diabetes now have a new option to care for the condition in their otherwise healthy pets. The U.S. Food and Drug Administration on Thursday approved the first pill to improve control of diabetes in some cats. The drug, calledContinue Reading
WEDNESDAY, Dec. 7, 2022 (HealthDay News) — Children with type 1 diabetes miss more school than their peers without this condition, but the good news is these absences don’t have to affect their grades or chances of going on to college, new research shows. Kids who had the tightest controlContinue Reading
WEDNESDAY, Nov. 23, 2022 (HealthDay News) — A century-old diabetes drug seems to help keep high-risk COVID-19 patients from falling deathly ill, a new study reports. Metformin reduced the risk of death from COVID-19 by 44% in a group of diabetics who were taking the drug when they became infectedContinue Reading
TUESDAY, Nov. 22, 2022 (HealthDay News) — Eating a Thanksgiving feast, while still maintaining healthy blood sugar levels, may seem challenging if you have diabetes, but it’s doable, experts say. Nearly 40 million Americans deal with this issue every day, and not just for holiday meals. To start: Don’t skipContinue Reading
FRIDAY, Nov. 18, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Thursday approved the first drug that could delay the development of type 1 diabetes (T1D). Teplizumab (Tzield) targets the autoimmune issues that drive the disease, rather than its symptoms, making the medication a game changer. “Today’sContinue Reading
WEDNESDAY, Nov. 16, 2022 (HealthDay News) — California’s plan to manufacture its own insulin could be a huge money-saver for state residents with diabetes — and possibly be a model for other states, according to experts. Earlier this year, California announced an initiative to bring its own insulin products toContinue Reading
FRIDAY, Nov. 11, 2022 (HealthDay News) – Too little of the “sunshine vitamin” — vitamin D — in Black Americans could raise their odds of developing diabetes, new research suggests. Two new studies found an association between levels of vitamin D in the blood and insulin resistance, a precursor toContinue Reading
TUESDAY, Nov. 8, 2022 (HealthDay News) — Scientists have used a transplant procedure to apparently cure diabetes in lab mice, without the need for immune-suppressing drugs afterward. The success is a first step in developing a safer way to use cell transplants to possibly cure type 1 diabetes. But that’sContinue Reading
THURSDAY, Oct. 27, 2022 (HealthDay News) — People at risk for developing diabetes could help themselves now by eating fewer carbs, according to new research. While low-carb diets are a common next step for someone diagnosed with the disease, people who are prediabetic or with diabetes not treated with medicationContinue Reading
MONDAY, Oct. 24, 2022 (HealthDay News) — A finger that “locks” can be a telltale sign of another condition: Diabetes. Researchers suspected that this trigger finger, often in the ring finger or thumb, might indicate diabetes after frequently finding the condition in patients who had or developed diabetes. It’s characterizedContinue Reading
WEDNESDAY, Oct. 19, 2022 (HealthDay News) — An older class of type 2 diabetes drugs known as thiazolidinediones, or TZDs, may protect you from dementia down the road, according to new research. Thiazolidinediones, also known as glitazones, cut dementia risk by 22% among folks at high risk who also hadContinue Reading